Xarelto meets goal in key long-term study EINSTEIN DVT study shows good benefit/risk profile-Bayer Study was first to compare Xarelto to warfarin (Adds details, background) FRANKFURT, Aug 4 (Reuters) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback